ACT Capital Management
Latest statistics and disclosures from Act Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are STAA, ARWR, ARCT, CLSD, NVDA, and represent 47.57% of Act Capital Management's stock portfolio.
- Added to shares of these 10 stocks: NVDA, DVN, LNTH, DOCN, SSYS, Qualtek Services, RRC, NVNO, EIGR, AFRM.
- Started 8 new stock positions in DVN, AFRM, RRC, BHVN, AVGR, LNTH, NVDA, Qualtek Services.
- Reduced shares in these 10 stocks: ARCT (-$6.1M), , , VIR, STAA, PUBM, AUPH, CVX, GDRX, NTRA.
- Sold out of its positions in AVXL, APVO, Avinger, CTRA, CCJ, FANG, FB, GDRX, HLMN, PUBM. TGTX, TMDX, UTHR, VIR, ONON.
- Act Capital Management was a net seller of stock by $-14M.
- Act Capital Management has $95M in assets under management (AUM), dropping by -31.67%.
- Central Index Key (CIK): 0001442273
Tip: Access up to 7 years of quarterly data
Positions held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Act Capital Management
Companies in the Act Capital Management portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Staar Surgical Com Par $0.01 (STAA) | 20.1 | $19M | -7% | 238k | 79.91 | |
| Arrowhead Pharmaceuticals (ARWR) | 9.8 | $9.2M | -4% | 201k | 45.99 | |
| Arcturus Therapeutics Hldg I (ARCT) | 7.2 | $6.8M | -47% | 253k | 26.96 | |
| Clearside Biomedical (CLSD) | 6.0 | $5.6M | 2.5M | 2.29 | ||
| NVIDIA Corporation (NVDA) | 4.5 | $4.2M | NEW | 16k | 272.84 | |
| Krystal Biotech (KRYS) | 4.2 | $3.9M | 59k | 66.54 | ||
| Stratasys SHS (SSYS) | 3.7 | $3.5M | +48% | 139k | 25.39 | |
| Devon Energy Corporation (DVN) | 2.8 | $2.6M | NEW | 45k | 59.12 | |
| Envveno Medical (NVNO) | 2.7 | $2.6M | +52% | 401k | 6.37 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.3 | $2.2M | NEW | 40k | 55.30 | |
| Eiger Biopharmaceuticals (EIGR) | 2.2 | $2.1M | +57% | 250k | 8.30 | |
| Ideaya Biosciences (IDYA) | 2.1 | $1.9M | 174k | 11.19 | ||
| Inmune Bio Ord (INMB) | 2.1 | $1.9M | 231k | 8.42 | ||
| Inhibikase Therapeutics (IKT) | 1.7 | $1.6M | 1.1M | 1.48 | ||
Setup an alertACT Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Adtran (ADTN) | 1.7 | $1.6M | -26% | 85k | 18.45 | |
| Digitalocean Hldgs (DOCN) | 1.5 | $1.4M | +455% | 25k | 57.84 | |
| Airsculpt Technologies (AIRS) | 1.5 | $1.4M | 102k | 13.68 | ||
| Affimed Therapeutics B V (AFMD) | 1.4 | $1.3M | 309k | 4.37 | ||
| Icad Com New (ICAD) | 1.4 | $1.3M | -9% | 295k | 4.46 | |
| Fubotv (FUBO) | 1.3 | $1.3M | -16% | 192k | 6.57 | |
| Qualtek Services Class A Com | 1.2 | $1.1M | NEW | 354k | 3.21 | |
| Myovant Sciences (MYOV) | 1.2 | $1.1M | 85k | 13.32 | ||
| Aspira Womens Health (AWH) | 1.1 | $1.0M | 1.0M | 1.04 | ||
| Zeta Global Holdings Corp Cl A (ZETA) | 1.0 | $924k | -46% | 73k | 12.74 | |
| Range Resources (RRC) | 1.0 | $911k | NEW | 30k | 30.37 | |
| Aurinia Pharmaceuticals (AUPH) | 0.9 | $836k | -64% | 68k | 12.39 | |
| Amazon (AMZN) | 0.7 | $652k | 200.00 | 3260.00 | ||
| Upstart Hldgs (UPST) | 0.6 | $600k | 5.5k | 109.09 | ||
| Coinbase Global Com Cl A (COIN) | 0.6 | $570k | 3.0k | 190.00 | ||
| Chevron Corporation (CVX) | 0.6 | $570k | -72% | 3.5k | 162.86 | |
| Natera (NTRA) | 0.5 | $509k | -61% | 13k | 40.72 | |
| Champions Oncology Com New (CSBR) | 0.5 | $508k | 63k | 8.13 | ||
| Surface Oncology (SURF) | 0.5 | $501k | 171k | 2.94 | ||
| Oncocyte (OCX) | 0.5 | $492k | 330k | 1.49 | ||
| Leap Therapeutics (LPTX) | 0.5 | $464k | +17% | 265k | 1.75 | |
| Global-e Online SHS (GLBE) | 0.4 | $422k | -44% | 13k | 33.76 | |
| Bioxcel Therapeutics (BTAI) | 0.4 | $418k | 20k | 20.90 | ||
| Neoleukin Therapeutics (NLTX) | 0.4 | $374k | -6% | 199k | 1.88 | |
| Pds Biotechnology Ord (PDSB) | 0.4 | $371k | 60k | 6.18 | ||
| Matterport Com Cl A (MTTR) | 0.3 | $325k | -27% | 40k | 8.12 | |
| Affirm Hldgs Com Cl A (AFRM) | 0.3 | $324k | NEW | 7.0k | 46.29 | |
| Draganfly Com New (DPRO) | 0.3 | $321k | -30% | 135k | 2.38 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $317k | 28k | 11.53 | ||
| Oncternal Therapeutics (ONCT) | 0.3 | $313k | -37% | 225k | 1.39 | |
| Immatics (IMTX) | 0.3 | $300k | -40% | 38k | 8.00 | |
| Cardiff Oncology (CRDF) | 0.3 | $299k | +17% | 121k | 2.48 | |
| Audacy Cl A (AUD) | 0.3 | $282k | 98k | 2.89 | ||
| Biohaven Pharmaceutical Holding (BHVN) | 0.3 | $249k | NEW | 2.1k | 118.57 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $196k | +18% | 48k | 4.13 | |
| Medicenna Therapeutics Corp. (MDNA) | 0.2 | $195k | 153k | 1.28 | ||
| Curis Com New (CRIS) | 0.2 | $190k | 80k | 2.38 | ||
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $185k | 90k | 2.06 | ||
| Lottery (LTRY) | 0.2 | $176k | -8% | 56k | 3.14 | |
| Mogo (MOGO) | 0.2 | $160k | 55k | 2.91 | ||
| Oyster Point Pharma (OYST) | 0.2 | $157k | 14k | 11.63 | ||
| Marker Therapeutics Ord (MRKR) | 0.2 | $156k | 354k | 0.44 | ||
| Cellectar Biosciences Com Par (CLRB) | 0.2 | $150k | 218k | 0.69 | ||
| Akerna Corp (KERN) | 0.2 | $146k | 128k | 1.14 | ||
| Transcode Therapeutics (RNAZ) | 0.2 | $144k | 50k | 2.88 | ||
| Akero Therapeutics (AKRO) | 0.2 | $142k | -25% | 10k | 14.20 | |
| Enlivex Therapeutics (ENLV) | 0.1 | $140k | 25k | 5.60 | ||
| Ampio Pharmaceuticals (AMPE) | 0.1 | $137k | 292k | 0.47 | ||
| Cbdmd (YCBD) | 0.1 | $130k | 125k | 1.04 | ||
| Helius Med Technologies Com Cl A New (HSDT) | 0.1 | $117k | 35k | 3.32 | ||
| Cytosorbents (CTSO) | 0.1 | $112k | 35k | 3.20 | ||
| Instil Bio (TIL) | 0.1 | $108k | 10k | 10.80 | ||
| Sio Gene Therapies Common (SIOX) | 0.1 | $98k | -20% | 147k | 0.67 | |
| Superior Drilling Products (SDPI) | 0.1 | $85k | -25% | 80k | 1.06 | |
| Atara Biotherapeutics (ATRA) | 0.1 | $85k | 9.2k | 9.24 | ||
| Sqz Biotech (SQZ) | 0.1 | $77k | 16k | 4.81 | ||
| Tracon Pharmaceuticals Com New (TCON) | 0.1 | $75k | 29k | 2.63 | ||
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.1 | $72k | 11k | 6.86 | ||
| Lottery *w Exp 05/09/2023 (LTRYW) | 0.1 | $61k | 125k | 0.49 | ||
| Yalla Group Ads (YALA) | 0.1 | $60k | 14k | 4.44 | ||
| Cyteir Therapeutics (CYT) | 0.1 | $57k | 15k | 3.80 | ||
| Bioline Rx Sponsored Ads (BLRX) | 0.0 | $47k | 28k | 1.71 | ||
| Syros Pharmaceuticals (SYRS) | 0.0 | $42k | +62% | 35k | 1.20 | |
| Applied Therapeutics (APLT) | 0.0 | $42k | 20k | 2.10 | ||
| Aravive (ARAV) | 0.0 | $34k | +75% | 18k | 1.94 | |
| Actinium Pharmaceuticals (ATNM) | 0.0 | $33k | -82% | 6.5k | 5.08 | |
| Nektar Therapeutics (NKTR) | 0.0 | $32k | -86% | 6.0k | 5.33 | |
| Genetron Holdings Ads (GTH) | 0.0 | $16k | 7.5k | 2.13 | ||
| Airbnb Com Cl A (ABNB) | 0.0 | $9.0k | 50.00 | 180.00 | ||
| Genocea Biosciences Com New (GNCA) | 0.0 | $6.0k | 5.0k | 1.20 | ||
| Avinger Com New (AVGR) | 0.0 | $6.0k | NEW | 1.8k | 3.43 | |
Past Filings by Act Capital Management
SEC 13F filings are viewable for Act Capital Management going back to 2021
- Act Capital Management 2022 Q1 filed May 11, 2022
- Act Capital Management 2021 Q4 filed Feb. 3, 2022
- ACT Capital 2021 Q3 filed Nov. 16, 2021
- ACT Capital Management 2021 Q2 filed Aug. 16, 2021